RxNorm 1357541 NDC Crossover
tofacitinib 5 MG Oral Tablet
Related NDC Codes to RxNorm Concept 1357541
The following NDC codes crossover to the RxNorm Concept 1357541. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
0069-0501 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-0502 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-1001 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-1002 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-1029 | Xeljanz | Tofacitinib | Solution | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
63539-012 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | ACTIVE | |
63539-016 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | ACTIVE | |
63539-501 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | ACTIVE | |
63539-502 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | ACTIVE |